Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma

7 Oct 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors
Share to Signaling Pathways in Disease

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36207403
DOI: 10.1038/s41401-022-00999-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastomaPMID 36207403Read ↗

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against CancerSemantic proximity Read ↗

Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of GlioblastomaSemantic proximity Read ↗

Advances Toward Lsd1 Inhibitors for Cancer TherapySemantic proximity Read ↗

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and ChallengesSemantic proximity Read ↗

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastomaSemantic proximity Read ↗

Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitationsSemantic proximity Read ↗

Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC InteractionSemantic proximity Read ↗

Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applicationsSemantic proximity Read ↗

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and ProgressionSemantic proximity Read ↗

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastomaSemantic proximity Read ↗

Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseasesSemantic proximity Read ↗

RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.